AUXLY CANNABIS GROUP INC (XLY.CA) Stock Price & Overview
TSX:XLY • CA05335P1099
The current stock price of XLY.CA is 0.125 CAD. Today XLY.CA is up by 4.17%. In the past month the price decreased by -3.85%. In the past year, price increased by 78.57%.
XLY.CA Key Statistics
- Market Cap
- 170.88M
- P/E
- 3.13
- Fwd P/E
- 12.38
- EPS (TTM)
- 0.04
- Dividend Yield
- N/A
XLY.CA Stock Performance
XLY.CA Stock Chart
XLY.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to XLY.CA. When comparing the yearly performance of all stocks, XLY.CA is one of the better performing stocks in the market, outperforming 71.12% of all stocks.
XLY.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to XLY.CA. XLY.CA has only an average score on both its financial health and profitability.
XLY.CA Earnings
On November 13, 2025 XLY.CA reported an EPS of 0.01 and a revenue of 40.55M.
XLY.CA Forecast & Estimates
5 analysts have analysed XLY.CA and the average price target is 0.26 CAD. This implies a price increase of 104% is expected in the next year compared to the current price of 0.125.
For the next year, analysts expect an EPS growth of 210.75% and a revenue growth 14.35% for XLY.CA
XLY.CA Groups
Sector & Classification
XLY.CA Financial Highlights
Over the last trailing twelve months XLY.CA reported a non-GAAP Earnings per Share(EPS) of 0.04. The EPS increased by 151.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 31.05% | ||
| ROA | 16.4% | ||
| ROE | 26.28% | ||
| Debt/Equity | 0.3 |
XLY.CA Ownership
XLY.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.23 | 2.687B | ||
| CRON | CRONOS GROUP INC | 39.13 | 1.3B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.162B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 7.29 | 918.667M | ||
| DHT-U | DRI HEALTHCARE TRUST | 5.1 | 642.517M | ||
| GUD | KNIGHT THERAPEUTICS INC | 129.23 | 612.126M | ||
| WEED | CANOPY GROWTH CORP | N/A | 590.015M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 451.829M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 18.16 | 374.397M | ||
| TSND | TERRASCEND CORP | N/A | 345.979M | ||
| HITI | HIGH TIDE INC | 24.27 | 294.431M | ||
| ACB | AURORA CANNABIS INC | 59.28 | 271.641M | ||
| OGI | ORGANIGRAM GLOBAL INC | 28.75 | 264.855M |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find more growth stocks the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About XLY.CA
Company Profile
Auxly Cannabis Group, Inc. engages in developing, manufacturing, and distributing branded cannabis products for wellness and recreational consumers. The company is headquartered in Toronto, Ontario and currently employs 388 full-time employees. The company went IPO on 2001-08-20. Its brands include Foray, Kolab Project, Back Forty, Dosecann, and Parcel. Foray is a versatile, modern, and inviting cannabis brand, designed for the curious. Kolab Project offers a refined collection of cannabis products and design-focused, purposeful goods. The firm also engages in wholesale bulk cannabis transactions with various licensed producers in Canada. Its subsidiaries are Auxly Charlottetown Inc., Auxly Ottawa Inc. and Auxly Leamington Inc. Its primary Cannabis 2.0 Product development, manufacturing and R&D activities are conducted by its subsidiary Auxly Charlottetown Inc. at a cannabis processing facility located in Charlottetown, Prince Edward Island. Auxly Ottawa Inc. holds licenses for cultivation and processing under the cannabis act and conducts the Company’s primary dried flower and pre-roll manufacturing.
Company Info
IPO: 2001-08-20
AUXLY CANNABIS GROUP INC
777 Richmond St. W, Unit 002
TORONTO ONTARIO M6J 0C2 CA
CEO: Hugo Alves
Employees: 388
Phone: 16478120121
AUXLY CANNABIS GROUP INC / XLY.CA FAQ
What does AUXLY CANNABIS GROUP INC do?
Auxly Cannabis Group, Inc. engages in developing, manufacturing, and distributing branded cannabis products for wellness and recreational consumers. The company is headquartered in Toronto, Ontario and currently employs 388 full-time employees. The company went IPO on 2001-08-20. Its brands include Foray, Kolab Project, Back Forty, Dosecann, and Parcel. Foray is a versatile, modern, and inviting cannabis brand, designed for the curious. Kolab Project offers a refined collection of cannabis products and design-focused, purposeful goods. The firm also engages in wholesale bulk cannabis transactions with various licensed producers in Canada. Its subsidiaries are Auxly Charlottetown Inc., Auxly Ottawa Inc. and Auxly Leamington Inc. Its primary Cannabis 2.0 Product development, manufacturing and R&D activities are conducted by its subsidiary Auxly Charlottetown Inc. at a cannabis processing facility located in Charlottetown, Prince Edward Island. Auxly Ottawa Inc. holds licenses for cultivation and processing under the cannabis act and conducts the Company’s primary dried flower and pre-roll manufacturing.
Can you provide the latest stock price for AUXLY CANNABIS GROUP INC?
The current stock price of XLY.CA is 0.125 CAD. The price increased by 4.17% in the last trading session.
What is the dividend status of AUXLY CANNABIS GROUP INC?
XLY.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of XLY stock?
XLY.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Would investing in AUXLY CANNABIS GROUP INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on XLY.CA.
Can you provide the growth outlook for AUXLY CANNABIS GROUP INC?
The Revenue of AUXLY CANNABIS GROUP INC (XLY.CA) is expected to grow by 14.35% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the next earnings date for XLY stock?
AUXLY CANNABIS GROUP INC (XLY.CA) will report earnings on 2026-03-26, after the market close.